--ggg, thanks Marsh. I actually did not expect such a bloody day<g>. but looks like CELG did present some new data today at the ASCO meeting, which will increase their sales and bottom line revenue. So don't hold the short for too long<g>. The near term down side is around $37ish, but on a good day, they may push it back to 44-45 or break to ATH.
Plus, some malicious people make the buyout rumor once in a while, I saw once last year, once this year, and I haven't even followed this stock for long<g>